Double your impact for the melanoma community today on #GivingTuesday

Guest blog post by Katonya Breaux, Founder, Unsun Cosmetics and MRF advocate:   I discovered moles on my face that I thought were genetic, but after a visit to the dermato...

Guest blog post by Samantha Buirski, ocular melanoma patient, advocate and member of the CURE OM Patient Steering Committee: Being part of a rare community is challenging. ...

Guest blog post by Kristin R. McJunkins, Stage III melanoma survivor and advocate: In 2008 when I was 38 years old, I was diagnosed with Stage IIIa cutaneous melanoma. Afte...

The MRF is proud to share the following press release from the Congressionally Directed Medical Research Program announcing MRF Board Chair (and melanoma survivor) Doug Bro...

Guest blog post by Richard K. Lodwick, OD: As I explain to most every patient, the view into the eye is a direct view into the body. Within the eye we have access to nerves...

Guest blog post by ocular melanoma patient and advocate Karen Kaludov: When I was in college, a doctor told me my goal was to not get skin cancer before I was 40. The docto...

Guest blog post by ocular melanoma survivor and advocate Sara Haven Rusch:  I got lucky. In 2016 I was 8 months pregnant. I went to a routine eye exam in order toÂ...

Washington, DC (November 2) – The Melanoma Research Foundation, the largest independent organization devoted to melanoma, today announced that it will be acquiring the Ch...

Guest blog post by Vernon K. Sondak, MD (Department of Cutaneous Oncology, Moffitt Cancer Center), with Jane L. Messina, MD (Departments of Cutaneous Oncology and Anatomic ...

Guest blog post by Elena Hawryluk, MD, PhD, pediatric dermatologist at Boston Children’s Hospital and member of the MRF’s Pediatric Melanoma Scientific Steering...

Guest blog post by Vernon K. Sondak, MD (Department of Cutaneous Oncology, Moffitt Cancer Center), with Jane L. Messina, MD (Departments of Cutaneous Oncology and Anatomic ...